Original Research
Published on 21 Jul 2021
Abiraterone In Vitro Is Superior to Enzalutamide in Response to Ionizing Radiation
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.700543
- 7,437 views
- 9 citations
67 articles related to "Abiraterone"
Articles
Systematic Review
Published on 31 Oct 2023
Comparative efficacy of olaparib in combination with or without novel antiandrogens for treating metastatic castration-resistant prostate cancer
in Cancer Endocrinology
Frontiers in Endocrinology
doi 10.3389/fendo.2023.1225033
- 5,200 views
- 4 citations
Original Research
Published on 09 Dec 2025
Qiling decoction enhances the anti-tumor activity of abiraterone acetate by up-regulating miR-143 expression in abiraterone acetate-resistant prostate cancer cells
in Pathology
Frontiers in Medicine
doi 10.3389/fmed.2025.1643506
- 815 views
Original Research
Published on 22 Jul 2022
Biotransformation of Abiraterone Into Five Characteristic Metabolites by the Rat Gut Microbiota and Liver Microsomes
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.890323
- 3,444 views
- 5 citations
Original Research
Published on 18 May 2021
Treatment-Emergent Co-Morbidities and Survival in Patients With Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone or Enzalutamide
in Drugs Outcomes Research and Policies
Frontiers in Pharmacology
doi 10.3389/fphar.2021.669236
- 5,763 views
- 8 citations
Case Report
Published on 08 Apr 2020
Abiraterone Rechallenge Based on Sequential Testing of Androgen Receptor Splice Variant 7 Expression in Circulating Tumor Cells: A Case Report
in Pharmacology of Anti-Cancer Drugs
Frontiers in Oncology
doi 10.3389/fonc.2020.00495
- 4,824 views
- 6 citations
Case Report
Published on 29 Jun 2023
Fatal fulminant hepatitis in a patient taking abiraterone acetate: a case report
in Translational Medicine
Frontiers in Medicine
doi 10.3389/fmed.2023.1143244
- 5,051 views
- 3 citations
Original Research
Published on 07 Mar 2022
Comparative Effectiveness of Abiraterone and Enzalutamide in Patients With Metastatic Castration-Resistant Prostate Cancer in Taiwan
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.822375
- 11,299 views
- 10 citations
Original Research
Published on 18 Jun 2021
Real-World Data on Outcomes in Metastatic Castrate-Resistant Prostate Cancer Patients Treated With Abiraterone or Enzalutamide: A Regional Experience
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.656146
- 8,002 views
- 12 citations
Systematic Review
Published on 27 Aug 2021
Efficacy and Safety of Abiraterone Acetate and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer: A Systematic Review and Meta-Analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.732599
- 12,661 views
- 13 citations
Case Report
Published on 11 Apr 2025
Case Report: Abiraterone in brain metastases from prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1555897
- 2,241 views
Systematic Review
Published on 18 Sep 2020
Comparison of Current Systemic Combination Therapies for Metastatic Hormone-Sensitive Prostate Cancer and Selection of Candidates for Optimal Treatment: A Systematic Review and Bayesian Network Meta-Analysis
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.519388
- 12,022 views
- 25 citations
Original Research
Published on 13 Oct 2025
Efficacy and safety of apalutamide, abiraterone acetate, and bicalutamide in the treatment of metastatic hormone-sensitive prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1656216
- 2,850 views
Original Research
Published on 04 Dec 2020
Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2020.606133
- 2,855 views
- 2 citations
Original Research
Published on 27 Jan 2025
An MRI radiomics model for predicting a prostate-specific antigen response following abiraterone treatment in patients with metastatic castration-resistant prostate cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1491848
- 2,218 views
- 2 citations
Original Research
Published on 24 Feb 2021
A Cost-Effectiveness Analysis of Systemic Therapy for Metastatic Hormone-Sensitive Prostate Cancer
in Genitourinary Oncology
Frontiers in Oncology
doi 10.3389/fonc.2021.627083
- 10,528 views
- 27 citations